Pharmacology - Enoxaparin
Pharmacology - Enoxaparin This prevents the blood from coagulating. Method of Operation Antithrombin III (ATIII) is able to accelerate its action, which in turn increases its ability to inactivate Factor Xa. injected through a subcutaneous space. The
Pharmacology - Warfarin
Pharmacology - Warfarin This prevents the blood from coagulating. Mode of Action Performs the function of inhibiting the reduction of vitamin K, which in turn prevents the gamma carboxylation of the glutamate residues found in factors II, VII, IX, and
Pharmacology - Folic Acid
Pharmacology - Folic Acid Folic acid is necessary for the production of DNA as well as the proliferation of cells. When it is in its tetrahydrofolate (FH4) form, it functions as a cofactor in the synthesis of purines and pyrimidines, with thymidylate pro
Pharmacology - hydroxocobalamin
Pharmacology - hydroxocobalamin Restores the blood picture in megaloblastic anemias, such as pernicious anemia, and leads to a partial to complete recovery of the neurological condition, which is characterized by subacute combined degeneration of the spi
Pharmacology - Epoetin
Pharmacology - Epoetin To stimulate proliferation and differentiation, it attaches to receptors on committed erythrocyte progenitor cells and causes them to become activated. Injections can be administered intravenously or subcutaneously. Use in Clinic
Pharmacology - Glyceryl Trinitrate
Pharmacology - Glyceryl Trinitrate As a result of its ability to relax and relax vascular smooth muscle, particularly venular smooth muscle, glyceryl trinitrate has the ability to (i) reduce cardiac effort and, consequently, metabolic demand, and (ii) inc
Pharmacology - Digoxin
Pharmacology - Digoxin Pharmacology: Digoxin's Mechanism of Action Causes the heart to slow down. slows the conduction of AV. It lengthens the refractory period of the AV node. In a heart that is failing, it increases the force of contraction. Plasma m
Pharmacology - Simvastatin
Pharmacology - Simvastatin According to pharmacology, simvastatin's action is to reduce LDL-C. Additionally, it results in a decrease in plasma triglycerides and an increase in HDL-C to a certain extent. Mode of Action Specific reversible competitive i
Pharmacology - Simvastatin
Pharmacology - Simvastatin The Gemfibrozil ( Fibrates) The presence of fibrates results in a significant reduction in plasma VLDL and, consequently, triglyceride levels; a moderate reduction in LDL-C; and a slight increase in HDL-C. Mode of Action Fi
Pharmacology - Ezetimibe
Pharmacology - Ezetimibe The action of Ezetimibe In particular, it prevents cholesterol from being absorbed from the intestines during digestion. A decrease in the concentration of LDL in plasma is the primary effect. Method of Operation The quantity
